PeptidePedia The community reference

Contributions of BalanceBirdie

User contributions·39 logged edits·page 1 of 1

Contributions by BalanceBirdie, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 105 edits includes activity predating the current log.

  1. 11:24, 24 Jul 2026 (diff | hist) Talk:Asymchem Laboratories 822 +190 /* Notability, and the oldest registry record on the wiki */ reply
  2. 06:49, 19 Jul 2026 (diff | hist) Methionine oxidation 5,001 ±0 convert a hard-coded date to the house format
  3. 13:22, 27 Jun 2026 (diff | hist) Talk:Sharps disposal 674 +407 /* Colour-coding table is England-specific and presented as general */ new section
  4. 13:55, 22 Jun 2026 (diff | hist) Talk:Cost per milligram 748 +60 /* Documentation is not in the price */ reply
  5. 10:20, 19 Jun 2026 (diff | hist) Talk:Analytical method validation 674 +172 /* Uncharacterised is not wrong */ new section
  6. 11:35, 11 Jun 2026 (diff | hist) Talk:Bacterial endotoxin test 674 +180 /* Absence of the determination */ new section
  7. 10:05, 4 Jun 2026 (diff | hist) Talk:Grey market 537 +104 /* Unknown is not bad */ new section
  8. 10:20, 27 May 2026 (diff | hist) Talk:Good manufacturing practice 537 +175 /* The uncomfortable inference */ new section
  9. 09:25, 15 May 2026 (diff | hist) Talk:Repackaging 537 +153 /* Not irregular */ new section
  10. 09:35, 8 May 2026 (diff | hist) Talk:Custom peptide synthesis 537 +178 /* Declining to quote */ new section
  11. 09:45, 7 May 2026 (diff | hist) Talk:Counterfeit peptide 537 +166 /* Declared excipients */ new section
  12. 10:15, 4 May 2026 (diff | hist) Talk:Number needed to treat 537 +210 /* Incommensurable outcomes */ new section
  13. 10:50, 22 Apr 2026 (diff | hist) Talk:Underfilling 537 +169 /* Overage section balances the article */ new section
  14. 09:20, 16 Apr 2026 (diff | hist) Talk:Global access disparity 822 +170 /* Framing of the access argument */ reply
  15. 10:40, 15 Apr 2026 (diff | hist) Talk:Loss on drying 537 +157 /* High figures are not defects */ new section
  16. 10:25, 5 Apr 2026 (diff | hist) Talk:SELECT trial 537 +157 /* Discontinuation rate in the summary */ new section
  17. 10:58, 1 Apr 2026 (diff | hist) Talk:Multi-dose vial 1,444 +92 /* Weight of the outbreak section */ reply
  18. 13:07, 30 Mar 2026 (diff | hist) Talk:Multi-dose vial 811 +316 /* Weight of the outbreak section */ new section
  19. 11:30, 19 Mar 2026 (diff | hist) Talk:Satiety signalling 537 +103 /* Energy expenditure claim */ new section
  20. 13:25, 13 Mar 2026 (diff | hist) Talk:Crude peptide 611 +130 /* Crude is not a pejorative */ reply
  21. 07:13, 22 Jan 2026 (diff | hist) Insulin syringe unit conversion 6,290 ±0 add the axis labels to the inline bar figure
  22. 11:30, 17 Jan 2026 (diff | hist) Talk:GLP-1 receptor agonist 537 +223 /* Should class-level cardiovascular benefit be claimed? */ new section
  23. 15:02, 4 Dec 2025 (diff | hist) Talk:Xi'an Mokemei Biotechnology 1,033 +282 /* Should the lot-identifier check be described on every supplier article? */ reply
  24. 09:46, 11 Oct 2025 (diff | hist) Syringe dead space 8,611 +662 space between number and unit per PP:MOS
  25. 09:44, 21 Aug 2025 (diff | hist) Talk:Qingdao Saber Technology Pharmaceutical 1,170 +108 /* Appearance and purity are separate observations */ reply
  26. 10:28, 19 Aug 2025 (diff | hist) Talk:Qingdao Saber Technology Pharmaceutical 537 +218 /* Appearance and purity are separate observations */ new section
  27. 11:35, 8 Aug 2025 (diff | hist) Talk:Tianjin Finder Chemical 1,170 +178 /* Certificate date and dispatch date */ reply
  28. 10:19, 6 Aug 2025 (diff | hist) Talk:Tianjin Finder Chemical 537 +274 /* Certificate date and dispatch date */ new section
  29. 19:51, 27 Jun 2025 (diff | hist) ChinaPeptides 9,996 +485 expand §Reception
  30. 20:58, 6 May 2025 (diff | hist) ISO 9001 3,379 +39 expand §What it implies about material
  31. 09:33, 28 Apr 2025 (diff | hist) Talk:Qingdao Sigma Chemical 537 +233 /* Reporting a tally count without implying a ranking */ new section
  32. 20:04, 26 Apr 2025 (diff | hist) Trial data comparison 4,355 +332 rm the administration advice; the tool computes, it does not instruct
  33. 17:26, 21 Apr 2025 (diff | hist) Peptide synthesis 4,134 +21 m expand §Why yield falls with length
  34. 03:49, 23 Jan 2025 (diff | hist) Insulin syringe unit conversion 3,205 +119 m expand §Scale comparison
  35. 14:48, 20 Jan 2025 (diff | hist) Talk:Bachem Holding (Suzhou) 1,244 +207 /* The name coincidence: how much should the article say? */ reply
  36. 20:56, 21 Dec 2024 (diff | hist) Beta cell function 4,236 +1,074 add the citation for the co-secretion finding
  37. 11:52, 16 Dec 2024 (diff | hist) Orforglipron 2,355 ±0 add the receptor targets to the lead sentence
  38. 05:50, 29 Nov 2024 (diff | hist) Peptide stability table 1,273 +1,273 N new article: reference tool, expansion welcome
  39. 05:22, 28 Aug 2024 (diff | hist) Reconstitution of lyophilised peptides 2,854 ±0 m rm the brand-specific instruction; it is not general